Neutrogena®, Aveeno®, and Regaine® Present New Scientific Evidence Demonstrating How Science-Backed Ingredients Support Healthy Skin and Hair
Business Wire•30/09/2026•06:45 ET
0
Key Highlights
- ➤12 new data sets from Neutrogena, Aveeno and Regaine presented at EADV 2026
- ➤Neutrogena sunscreen study showed 56% lower redness and 46% lower acne hyperpigmentation
- ➤Neutrogena niacinamide sunscreen delivered 22% improved hydration after 28 days
- ➤Aveeno survey found 92.7% of clinicians observed steroid-sparing or optimization effects
- ➤Regaine 5% minoxidil delivered greater regrowth among younger men and earlier-stage hair loss
Expert Statements
Kate Stockman, Vice President and Head of EMEA Research & Development at Kenvue
“Consumers consistently tell us that healthy skin and healthy hair can have a meaningful impact on their confidence and quality of life.”
Kate Stockman, Vice President and Head of EMEA Research & Development at Kenvue
“The research we are presenting at EADV advances our understanding of how ingredients such as niacinamide, colloidal oat and 5% minoxidil can support skin barrier health, improve visible skin concerns and promote hair regrowth, respectively.”
Kate Stockman, Vice President and Head of EMEA Research & Development at Kenvue
“We are proud to continue partnering with the dermatology community to advance the science of skin and hair health through rigorous research and innovation.”
Neutrogena(®), Aveeno(®), and Regaine(®) Present New Scientific Evidence Demonstrating How Science-Backed Ingredients Support Healthy Skin and Hair
Research shared at the 35th European Academy of Dermatology and Venereology (EADV) Congress highlights the benefits of multifunctional sunscreens, colloidal oat formulations addressing acne, hyperpigmentation, eczema, UV-related skin damage, and the impact of 5% minoxidil for alopecia.
Get started
Create a free account to read the full story.